| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Interference | 17 | 2017 | 376 | 2.010 |
Why?
|
| RNA, Small Interfering | 12 | 2016 | 557 | 1.480 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2021 | 618 | 1.350 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2020 | 121 | 1.310 |
Why?
|
| Receptors, Androgen | 5 | 2020 | 123 | 1.270 |
Why?
|
| Oncogene Proteins | 2 | 2018 | 61 | 1.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2020 | 122 | 0.950 |
Why?
|
| Genomics | 6 | 2020 | 762 | 0.860 |
Why?
|
| Multiprotein Complexes | 3 | 2019 | 96 | 0.840 |
Why?
|
| Sarcoma, Ewing | 1 | 2022 | 44 | 0.840 |
Why?
|
| DNA Replication | 2 | 2019 | 170 | 0.820 |
Why?
|
| Cell Division | 4 | 2008 | 696 | 0.820 |
Why?
|
| Lentivirus | 1 | 2021 | 43 | 0.770 |
Why?
|
| DNA Damage | 2 | 2020 | 371 | 0.770 |
Why?
|
| Plicamycin | 2 | 2020 | 9 | 0.760 |
Why?
|
| DNA Repair | 2 | 2020 | 362 | 0.750 |
Why?
|
| Endoribonucleases | 4 | 2007 | 94 | 0.750 |
Why?
|
| Transcription Factors | 9 | 2023 | 1653 | 0.730 |
Why?
|
| Cell Line, Tumor | 13 | 2022 | 2558 | 0.730 |
Why?
|
| Drug Discovery | 1 | 2021 | 107 | 0.710 |
Why?
|
| Lung Neoplasms | 5 | 2021 | 2362 | 0.700 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2019 | 4 | 0.700 |
Why?
|
| Genetic Vectors | 2 | 2021 | 446 | 0.700 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 116 | 0.680 |
Why?
|
| DNA Helicases | 1 | 2019 | 84 | 0.660 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2021 | 1120 | 0.640 |
Why?
|
| Biomarkers, Tumor | 4 | 2021 | 1549 | 0.630 |
Why?
|
| PPAR gamma | 2 | 2018 | 73 | 0.620 |
Why?
|
| Glioblastoma | 4 | 2023 | 265 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2022 | 1265 | 0.600 |
Why?
|
| Tripartite Motif Proteins | 1 | 2016 | 3 | 0.560 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 1365 | 0.540 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 2415 | 0.540 |
Why?
|
| Carrier Proteins | 1 | 2019 | 681 | 0.540 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 172 | 0.510 |
Why?
|
| Prostatic Neoplasms | 3 | 2016 | 1769 | 0.470 |
Why?
|
| Mutation | 5 | 2021 | 4143 | 0.470 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 73 | 0.460 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2022 | 65 | 0.450 |
Why?
|
| HeLa Cells | 10 | 2016 | 511 | 0.450 |
Why?
|
| Endopeptidases | 1 | 2014 | 117 | 0.450 |
Why?
|
| Humans | 54 | 2023 | 89357 | 0.430 |
Why?
|
| Chromatin | 5 | 2023 | 397 | 0.420 |
Why?
|
| Genome, Human | 5 | 2017 | 767 | 0.420 |
Why?
|
| Gene Regulatory Networks | 3 | 2023 | 308 | 0.420 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 490 | 0.390 |
Why?
|
| Animals | 32 | 2023 | 27371 | 0.390 |
Why?
|
| Gene Library | 4 | 2008 | 133 | 0.390 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 726 | 0.390 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2022 | 133 | 0.330 |
Why?
|
| Mammals | 2 | 2008 | 235 | 0.330 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2008 | 30 | 0.330 |
Why?
|
| Neoplasms | 3 | 2021 | 3041 | 0.320 |
Why?
|
| Glioma | 2 | 2023 | 294 | 0.320 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 1157 | 0.310 |
Why?
|
| Mice | 17 | 2023 | 11761 | 0.310 |
Why?
|
| Systems Biology | 1 | 2008 | 44 | 0.300 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2013 | 135 | 0.300 |
Why?
|
| Ribonuclease III | 2 | 2016 | 16 | 0.290 |
Why?
|
| Genomic Library | 1 | 2007 | 33 | 0.290 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1652 | 0.290 |
Why?
|
| Ubiquitination | 3 | 2016 | 73 | 0.280 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 148 | 0.280 |
Why?
|
| Chromosomes, Human, Y | 2 | 2004 | 23 | 0.280 |
Why?
|
| Breast Neoplasms | 6 | 2021 | 3011 | 0.280 |
Why?
|
| Drosophila melanogaster | 6 | 2019 | 613 | 0.270 |
Why?
|
| Homeodomain Proteins | 4 | 2014 | 556 | 0.260 |
Why?
|
| RNA, Double-Stranded | 1 | 2005 | 22 | 0.260 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2016 | 17 | 0.260 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 645 | 0.250 |
Why?
|
| Genes, Essential | 1 | 2004 | 20 | 0.250 |
Why?
|
| Centrosome | 3 | 2009 | 22 | 0.240 |
Why?
|
| Spindle Apparatus | 4 | 2009 | 65 | 0.240 |
Why?
|
| Pediculus | 1 | 2003 | 3 | 0.230 |
Why?
|
| Clothing | 1 | 2003 | 7 | 0.230 |
Why?
|
| Stem Cells | 2 | 2017 | 372 | 0.220 |
Why?
|
| Cell Nucleus | 2 | 2023 | 599 | 0.220 |
Why?
|
| Mice, SCID | 4 | 2020 | 261 | 0.220 |
Why?
|
| Hepacivirus | 1 | 2004 | 130 | 0.220 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2022 | 3 | 0.220 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2022 | 8 | 0.210 |
Why?
|
| RNA, Viral | 1 | 2004 | 317 | 0.210 |
Why?
|
| Virus Replication | 1 | 2004 | 324 | 0.210 |
Why?
|
| Heart Conduction System | 1 | 2023 | 112 | 0.200 |
Why?
|
| Genetics, Population | 3 | 2010 | 406 | 0.200 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 782 | 0.200 |
Why?
|
| Gamma Rays | 1 | 2021 | 73 | 0.200 |
Why?
|
| Myocardial Contraction | 1 | 2023 | 252 | 0.190 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2021 | 10 | 0.190 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 195 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 20 | 0.190 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2013 | 47 | 0.190 |
Why?
|
| Drosophila Proteins | 4 | 2017 | 509 | 0.190 |
Why?
|
| Evolution, Molecular | 3 | 2004 | 841 | 0.190 |
Why?
|
| Protein Binding | 5 | 2016 | 1488 | 0.190 |
Why?
|
| Gene Expression | 2 | 2021 | 1310 | 0.190 |
Why?
|
| Binding Sites | 5 | 2017 | 1117 | 0.190 |
Why?
|
| Cellular Senescence | 1 | 2021 | 103 | 0.180 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 445 | 0.180 |
Why?
|
| Molecular Sequence Data | 5 | 2006 | 3027 | 0.180 |
Why?
|
| Male | 14 | 2020 | 42411 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 9 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 21 | 0.180 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 413 | 0.180 |
Why?
|
| Thrombospondin 1 | 1 | 2020 | 21 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 447 | 0.170 |
Why?
|
| DNA | 2 | 2006 | 1308 | 0.170 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 2 | 2017 | 4 | 0.170 |
Why?
|
| Tamoxifen | 1 | 2020 | 168 | 0.170 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 101 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 922 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2009 | 184 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2019 | 80 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1431 | 0.170 |
Why?
|
| Fertility | 1 | 2019 | 117 | 0.170 |
Why?
|
| Molecular Structure | 1 | 2019 | 290 | 0.160 |
Why?
|
| Proteolysis | 2 | 2016 | 110 | 0.160 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 173 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 66 | 0.160 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2018 | 22 | 0.160 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2019 | 109 | 0.160 |
Why?
|
| Microsatellite Repeats | 3 | 2004 | 148 | 0.160 |
Why?
|
| Adiposity | 1 | 2018 | 76 | 0.160 |
Why?
|
| Cytogenetic Analysis | 1 | 2018 | 71 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 136 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1525 | 0.150 |
Why?
|
| Base Sequence | 4 | 2006 | 2327 | 0.150 |
Why?
|
| Lysine | 1 | 2018 | 150 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 463 | 0.150 |
Why?
|
| Phenylthiohydantoin | 1 | 2017 | 48 | 0.150 |
Why?
|
| Nitriles | 2 | 2017 | 160 | 0.150 |
Why?
|
| Bridged-Ring Compounds | 1 | 2017 | 13 | 0.150 |
Why?
|
| Transfection | 3 | 2016 | 911 | 0.150 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 13 | 0.150 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2017 | 5 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 266 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1942 | 0.140 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 21 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 162 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2016 | 640 | 0.140 |
Why?
|
| Models, Molecular | 1 | 2021 | 1303 | 0.140 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 114 | 0.140 |
Why?
|
| Taxoids | 1 | 2017 | 130 | 0.140 |
Why?
|
| Androgen Antagonists | 1 | 2017 | 154 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 171 | 0.140 |
Why?
|
| Cytokinesis | 2 | 2009 | 57 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 414 | 0.140 |
Why?
|
| Carboplatin | 1 | 2017 | 312 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 146 | 0.130 |
Why?
|
| Mitosis | 2 | 2008 | 152 | 0.130 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 146 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 28 | 0.130 |
Why?
|
| RNA, Nuclear | 1 | 2015 | 3 | 0.130 |
Why?
|
| Microscopy, Video | 2 | 2005 | 34 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 111 | 0.120 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 23 | 0.120 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2015 | 12 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 53 | 0.120 |
Why?
|
| Trimetazidine | 1 | 2014 | 3 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2014 | 44 | 0.120 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2014 | 10 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 152 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 481 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2014 | 3385 | 0.120 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 49 | 0.120 |
Why?
|
| Intestines | 1 | 2017 | 416 | 0.120 |
Why?
|
| Retinoblastoma Protein | 1 | 2014 | 67 | 0.120 |
Why?
|
| Cyanoacrylates | 1 | 2014 | 5 | 0.120 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 66 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 73 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 80 | 0.120 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2014 | 14 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 286 | 0.120 |
Why?
|
| Genome | 4 | 2019 | 386 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2014 | 1132 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2014 | 134 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 266 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 470 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2010 | 2401 | 0.110 |
Why?
|
| Brain | 2 | 2021 | 2285 | 0.110 |
Why?
|
| Telomere-Binding Proteins | 1 | 2013 | 14 | 0.110 |
Why?
|
| Insulin | 1 | 2018 | 1146 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2014 | 213 | 0.110 |
Why?
|
| PPAR delta | 1 | 2013 | 2 | 0.110 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 370 | 0.110 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 16 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 313 | 0.110 |
Why?
|
| Telomerase | 1 | 2013 | 62 | 0.110 |
Why?
|
| Receptor, ErbB-3 | 1 | 2012 | 20 | 0.110 |
Why?
|
| Melanoma | 1 | 2017 | 468 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 3 | 2021 | 1057 | 0.100 |
Why?
|
| Telomere | 1 | 2013 | 114 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 971 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 315 | 0.100 |
Why?
|
| Transgenes | 2 | 2011 | 185 | 0.100 |
Why?
|
| DNA Primers | 2 | 2003 | 543 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2016 | 551 | 0.100 |
Why?
|
| Phenotype | 3 | 2014 | 2440 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 437 | 0.090 |
Why?
|
| Genetic Therapy | 2 | 2004 | 370 | 0.090 |
Why?
|
| Female | 12 | 2021 | 46202 | 0.090 |
Why?
|
| Climate | 1 | 2010 | 58 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1976 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2017 | 211 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 638 | 0.090 |
Why?
|
| Body Patterning | 1 | 2011 | 216 | 0.090 |
Why?
|
| Kinetochores | 1 | 2009 | 7 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 280 | 0.080 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2009 | 123 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 80 | 0.080 |
Why?
|
| Astrocytes | 2 | 2021 | 141 | 0.080 |
Why?
|
| Gene Frequency | 3 | 2010 | 685 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2009 | 178 | 0.080 |
Why?
|
| Time Factors | 4 | 2010 | 5338 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 314 | 0.080 |
Why?
|
| Quality Control | 1 | 2008 | 117 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 221 | 0.080 |
Why?
|
| Genotype | 3 | 2015 | 1849 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 59 | 0.070 |
Why?
|
| Untranslated Regions | 1 | 2007 | 18 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2004 | 1374 | 0.070 |
Why?
|
| Germ Cells | 2 | 2019 | 130 | 0.070 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 374 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2021 | 501 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 605 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2340 | 0.070 |
Why?
|
| User-Computer Interface | 1 | 2007 | 187 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 742 | 0.060 |
Why?
|
| Saliva | 1 | 2006 | 124 | 0.060 |
Why?
|
| Estrogens | 2 | 2020 | 201 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2005 | 18 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 887 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2005 | 73 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 1214 | 0.060 |
Why?
|
| Replicon | 1 | 2004 | 7 | 0.060 |
Why?
|
| Embryo Culture Techniques | 1 | 2004 | 9 | 0.060 |
Why?
|
| CHO Cells | 2 | 2015 | 187 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2004 | 81 | 0.060 |
Why?
|
| Lice Infestations | 1 | 2003 | 3 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 183 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 136 | 0.060 |
Why?
|
| History, Ancient | 1 | 2003 | 74 | 0.060 |
Why?
|
| Histones | 2 | 2017 | 329 | 0.060 |
Why?
|
| Africa | 1 | 2003 | 101 | 0.060 |
Why?
|
| Cricetinae | 2 | 2015 | 558 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3218 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 352 | 0.050 |
Why?
|
| Germany | 1 | 2003 | 72 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2005 | 509 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2003 | 187 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 342 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2017 | 291 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 787 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2017 | 519 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 983 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2015 | 0.050 |
Why?
|
| Microchemistry | 1 | 2002 | 6 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2002 | 34 | 0.050 |
Why?
|
| Haplotypes | 1 | 2004 | 637 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2758 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 1242 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2021 | 59 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 28 | 0.050 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 29 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2004 | 478 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 1076 | 0.040 |
Why?
|
| Estradiol | 1 | 2020 | 251 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2005 | 945 | 0.040 |
Why?
|
| Linear Energy Transfer | 1 | 2019 | 5 | 0.040 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cell Line | 2 | 2018 | 2496 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 134 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 393 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2019 | 86 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2021 | 318 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1088 | 0.040 |
Why?
|
| SUMO-1 Protein | 1 | 2018 | 16 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2017 | 0.040 |
Why?
|
| Sumoylation | 1 | 2018 | 18 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 177 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 116 | 0.040 |
Why?
|
| Tubulin | 2 | 2009 | 59 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 684 | 0.040 |
Why?
|
| Enterocytes | 1 | 2017 | 18 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 20 | 0.040 |
Why?
|
| Hydrazones | 1 | 2017 | 7 | 0.040 |
Why?
|
| Androstenes | 1 | 2017 | 45 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 230 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 41 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 12 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2018 | 277 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2017 | 113 | 0.040 |
Why?
|
| Zebrafish | 1 | 2019 | 319 | 0.040 |
Why?
|
| Aminopyridines | 1 | 2017 | 40 | 0.040 |
Why?
|
| Benzazepines | 1 | 2017 | 64 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 94 | 0.040 |
Why?
|
| Benzamides | 1 | 2017 | 237 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 401 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 198 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 291 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 268 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 1109 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 172 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 259 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 275 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 126 | 0.030 |
Why?
|
| Aged | 4 | 2017 | 19165 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 100 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 221 | 0.030 |
Why?
|
| Transcription Factor 4 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 106 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 233 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2017 | 211 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 2015 | 19 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 755 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 6811 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 97 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 198 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 374 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 354 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 22 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1534 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 377 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 67 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 269 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 126 | 0.030 |
Why?
|
| Middle Aged | 4 | 2017 | 25974 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 803 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1717 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 127 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 267 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 187 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2012 | 33 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1671 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2011 | 53 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 172 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2884 | 0.020 |
Why?
|
| Genetic Fitness | 1 | 2011 | 38 | 0.020 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2010 | 11 | 0.020 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2010 | 19 | 0.020 |
Why?
|
| Retinoids | 1 | 2010 | 18 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 273 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2010 | 39 | 0.020 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2010 | 16 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2010 | 46 | 0.020 |
Why?
|
| Benzoates | 1 | 2010 | 33 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 48 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3666 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 695 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2872 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2303 | 0.020 |
Why?
|
| Geography | 1 | 2010 | 227 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2009 | 18 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2366 | 0.020 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2009 | 13 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2001 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2009 | 25 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 9057 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 404 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 33 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 3783 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2009 | 57 | 0.020 |
Why?
|
| Tretinoin | 1 | 2009 | 128 | 0.020 |
Why?
|
| Microtubules | 1 | 2009 | 123 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 507 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 52 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2008 | 115 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2008 | 232 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 565 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 661 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 1135 | 0.020 |
Why?
|
| Antigens | 1 | 2008 | 229 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 113 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 421 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 392 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2006 | 102 | 0.020 |
Why?
|
| Cefotaxime | 1 | 1985 | 5 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 8241 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1985 | 92 | 0.010 |
Why?
|
| Metoprolol | 1 | 1984 | 15 | 0.010 |
Why?
|
| Electroporation | 1 | 2004 | 57 | 0.010 |
Why?
|
| Kallikreins | 1 | 1984 | 49 | 0.010 |
Why?
|
| Nervous System | 1 | 2004 | 89 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 788 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1984 | 266 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2006 | 537 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1985 | 396 | 0.010 |
Why?
|
| Adult | 3 | 2017 | 26607 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 1187 | 0.010 |
Why?
|
| Hypertension | 1 | 1984 | 745 | 0.010 |
Why?
|
| Thrombin Time | 1 | 1985 | 4 | 0.000 |
Why?
|
| Ceftriaxone | 1 | 1985 | 9 | 0.000 |
Why?
|
| Partial Thromboplastin Time | 1 | 1985 | 18 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1985 | 53 | 0.000 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 1984 | 1 | 0.000 |
Why?
|
| 18-Hydroxydesoxycorticosterone | 1 | 1984 | 1 | 0.000 |
Why?
|
| Desoxycorticosterone | 1 | 1984 | 18 | 0.000 |
Why?
|
| Corticosterone | 1 | 1984 | 35 | 0.000 |
Why?
|
| Renin | 1 | 1984 | 67 | 0.000 |
Why?
|
| Aldosterone | 1 | 1984 | 56 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1984 | 302 | 0.000 |
Why?
|